Cholesterol depletion uncouples β-dystroglycans from discrete sarcolemmal domains, reducing the mechanical activity of skeletal muscle

Cellular Physiology and Biochemistry

Volumn 29, Issue 5-6, 2012, Pages 905-918

  Vega Moreno, Jesús ^a   Tirado Cortes, Aldo ^a   Álvarez, Rocío ^a   Irles, Claudine ^b   Mas Oliva, Jaime ^c   Ortega, Alicia ^a,b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Cholesterol; Lipid raft; Sarcolemma; Skeletal muscle; Dystroglycan

Indexed keywords

BETA DYSTROGLYCAN; CAVEOLIN 3; CHOLESTEROL; DYSTROPHIN; METHYL BETA CYCLODEXTRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; EXTENSOR DIGITORUM LONGUS MUSCLE; FATIGUE; HEART MUSCLE CONTRACTILE FORCE; IMMUNOREACTIVITY; INCUBATION TIME; LIPID RAFT; MALE; MUSCLE CONTRACTION; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOLEMMA; SKELETAL MUSCLE;

RATTUS;

EID: 84861410381     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000186933     Document Type: Article

References (55)

1. Steven JW: The complexities of Dystroglycans. Trends Biochem Sci 2001;26:118-124.
2. Bozzi M, Sciandra F, Ferri L, Torreri P, Pavoni E, Petrucci CT, Giardina B, Brancaccio A: Concerted mutation of Phe residues belonging to the β-dystroglycan ectodomain strongly inhibits the interaction with α-dystroglycan in vitro. FEBS J 2006;273:4929-4943. (Pubitemid 44583516)
3. Watanabe N, Toshikuni S, Satoru N, Ichizo N, Torahiko T: Cys669-Cys713 disulfide bridge formation is a key to dystroglycan cleavage and subunit association. Genes Cells 2007;12:75-88. (Pubitemid 44971098)
4. Bloch RJ, Gonzalez-Serratos H: Lateral force transmission across costameres in skeletal muscle. Exerc Sport Sci Rev 2003;31:73-78. (Pubitemid 36443764)
5. García-Pelagio KP, Bloch RJ, Ortega A, González-Serratos H: Biomechanics of the sarcolemma and costameres in single skeletal muscle fibres from normal and dystrophin-null mice. J Muscle Res Cell Motil 2011;31:323-336.
6. Ervasti JM, Campbell KP: A Role for the Dystrophin-Glycoprotein Complex as a Transmembrane Linker between Laminin and Actin. J Cell Biol 1993;122:809-823. (Pubitemid 23241091)
7. Masaki T, Matsumura K: Biological Role of Dystroglycan in Schwann cell Function and Its Implications in Peripheral Nervous System Diseases. J Biomed Biotechnol 2010;1-17.
8. Jani K, Schock F: Molecular Mechanisms of Mechanosensing in Muscle Development. Dev Dynam 2009;238:1526-1534.
9. Crosbiee RH, Yamada H, Venzkea PD, Lisantib PM, Campbell KP: Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. FEBS Letters 1998;427:279-282. (Pubitemid 28225074)
10. Hack AA, Cordier RL, Shoturma DI, Lam MY, Sweeney HL, McNally EM: Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc Natl Acad Sci USA 1999;96:10723-10728. (Pubitemid 29442211)
11. Hnia K, Zouiten D, Cantel S, Chazalette D, Hugon G: ZZ domain of dystrophin and utrophin: topology and mapping of a β-dystroglycan interaction site. Biochem J 2007;401:667-677. (Pubitemid 46219261)
12. Jung D, Bin Y, Jon M, Jeffrey SC, Campbell KP: Identification and Characterization of the Dystrophin Anchoring Site on b-Dystroglycan. J Biol Chem 1995;270:27305-27310.
13. Prins KW, Jill LH, Amisha M, Tate V, Ralston E, Ervasti JM: Dystrophin is a microtubule-associated protein. J Cell Biol 2009;186:363-369.
14. Brown SC, Torelli S, Brockington M, Yuva Y, Jimenez C, Feng L, Anderson L, Ugo I, Kroger S, Bushby K, Voit T, Sewry C, Muntoni F: Abnormalities in alphadystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol 2004;164:727-737. (Pubitemid 38364686)
15. Patton BL, Bing W, Yukie S, Tarumi K, Seburn L, Burgess WR: A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination. J Cell Science 2008;121:1593-1604. (Pubitemid 351911816)
16. Ohlendieck K, Campbell KP: Dystrophin-associated Proteins Are Greatly Reduced in Skeletal Muscle from mdx Mice. J Cell Biol 1991;115:1685-1694. (Pubitemid 21910008)
17. Sandona D, Romeo B: Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects. Expert Rev Mol Med 2009;11:1-27.
18. Solares-Pérez A, Álvarez R, Crosbiee RH, Vega MJ, Medina MJ, Estrada FJ, Ortega A, Coral VR: Altered calcium pump and secondary deficiency of.-sarcoglycan and microspan in sarcoplasmic reticulum membranes isolated from d-sarcoglycan knockout mice. Cell Calcium 2010;48:28-36.
19. Gupta V, Kawahara G, Gundry RS, Chen TA, Lencer IW, Zhou Y, Zon IL, Kunkel ML, Beggs HA: The zebra fish DAG1 mutant: A novel genetic model for dystroglycanopathies. Human Mol Gen 2011;20:1712-1725.
20. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell KP: Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum Mol Genet 1997;6:831-841. (Pubitemid 27239066)
21. Franzini-Armstrong C, Landmesser L, Pilar G: Size and shape of Transverse Tubule openings in frog twitch muscle fibres. J Cell Biol 1975;64:493-497.
22. Zampighi G, Vergara J, Ramón F: On the connection between the Transverse tubules and the Plasma Membrane in Frog Semitendinosus Skeletal Muscle. J Cell Biol 1975;64:734-740.
23. Galbiati F, Engelman AJ, Volonte D, Zhang LX, Minetti C, Li M, Hou H, Kneitz B, Edelmann W, Lisati MP: Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex and t-tubule abnormalities. J Biol Chem 2001;276:21425-21433.
24. Volonte D, Peoples AJ, Galbiati F: Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle: implication for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C. Mol Biol Cell 2003;10:4075-4078.
25. Murph RM, Janelle PM, Graham DL: Plasma membrane removal in rat skeletal muscle fibres reveals caveolin-3 hotspots at the necks of transverse tubules Exp Cell Res 2009;315:1015-1028.
26. Parton RG, Way M, Zorzi N, Stang E: Caveolin-3 Associates with Developing-tubules during Muscle Differentiation. J Cell Biology 1997;136:137-154. (Pubitemid 27044810)
27. Head BP, Patel HH, Roth DM, Lai NC, Niesman IR, Farquehar MG, Insel PA: Gproteincoupled receptor signalling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes. J Biol Chem 2005;280:31036-31044. (Pubitemid 41291837)
28. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, Faquhar MG, Insel PA: Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenyl cyclase signalling components. J Biol Chem 2006;281:26391-26399. (Pubitemid 44401847)
29. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 1997;387:569-572. (Pubitemid 27248754)
30. Carozzi AJ, Roy S, Morrow IC, Pol A, Wyse B, Clyde-Smith J, Prior IA, Nixon SJ, Hancock JF, Parton RG: Inhibition of lipid raft-dependent signalling by a dystrophy-associated mutant of caveolin-3. J Biol Chem 2002;277:17944- 17997.
31. Pouvreau S, Berthier C, Blaineau S, Amsellem J, Coronado R, Strube C: Membrane cholesterol modulates dihydropyridine receptor function in mice fetal skeletal muscle cells. J Physiology 2004;55:365-381. (Pubitemid 38379997)
32. Zidovetzki R, Levitan I: Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies. Biochem Biophys Acta 2007;1768:1311-1324. (Pubitemid 46782714)
33. Muños P, Rosemblatt M: Isolation and Characterization of distinct domains of sarcolemma and T-tubules from rat skeletal muscle. Biochem J 1995;307:273-280.
34. Rosemblatt M, Hidalgo C, Vergara C, Ikemoto N: Immunological and biochemical properties of transverse tubule membranes isolated from rabbit skeletal muscle. J Biol Chem 1981;256:8140-8148. (Pubitemid 12229852)
35. Ortega A, Lepock J: Use of thermal analysis to distinguish magnesium and calcium stimulated ATPase activity in isolated transverse tubule membranes from skeletal muscle. Biochem Biophys Acta 1995;1233:7-13.
36. Irles C, Arias-Martinez J, Guzmán-Bárcenas J, Ortega A: Plasma membrane subdomains partitioning of Lck in primary human T lymphocytes. Can J Physiol Pharmacol 2010;88:287-496.
37. + -ATPase ATP hydrolyzing activity in the human erythrocyte. Biochem Biophys Acta 1983;727:39-44. (Pubitemid 13186861)
38. Ortega A, Mas-Oliva J: Direct Regulatory Effect Of Cholesterol on the calmodulin stimulated calcium pump of cardiac sarcolemma. Biochem Biophys Res Comm 1986;139:868-874. (Pubitemid 17168477)
39. Petrov V, Lijnen P: Cholesterol modulation of transmembrane cation transport systems in human erythrocytes. Biochem Mol Med 1995;56:52-62.
40. Bukiya AN, Jitendra DB, Rychnovsky S, Dopico AM: Specificity of cholesterol and analogs to modulate BK channels points to direct sterol-channel protein interactions. J Gen Physiol 2011;137:93-110.
41. Epshtein Y, Chopra AP, Rosenhouse-Dantsker A, Kowalsky GB, Logothetis DE, Levitan I: Identification of a C-terminus domain critical for the sensitivity of Kir2.1 to cholesterol. Proc Natl Acad Sci USA 2009;106:8055-8060.
42. 1 ) responses in bovine airway smooth muscle: role of Rho-kinase. Can J Physiol Pharmacol 2009;87:180-195.
43. Reversi A, Rimoldi V, Brambillasca S, Chini B: Effects of cholesterol manipulation on the signalling of the human oxytocin receptor. Am J Physiol Regul Integr Comp Physiol 2006;291:R861-R869. (Pubitemid 44498424)
44. Borroni V, Barrantes FJ: Cholesterol modulates the rate and mechanism of acetylcholine receptor internalization. J Biol Chem 2011;286:17122-17132.
45. Pediconi MF, Donoso P, Hidalgo C, Barrantes FJ: Lipid composition of purified transverse tubule membranes isolated from amphibian skeletal muscle. Biochem Biophys Acta 1987;921:398-404.
46. Sabbadini RA, Dahms AS: Biochemical properties of isolated transverse tubular membranes. J Bioener Biomembr 1989;21:163-213. (Pubitemid 19143569)
47. Madden T, Quinn P, Chapman D: Cholesterol modulates activity of calciumdependent ATPase of the sarcoplasmic reticulum. Nature 1979;279:538-541. (Pubitemid 9195266)
48. Yancey PG, Rodrigueza WV, Kilsdonk E P C, Stoudt GW, Johnson WJ, Phillips MC, Rothblat GH: Cellular Cholesterol Efflux Mediated by Cyclodextrins. J Biol Chem 1996;271:16026-16034.
49. Van der Maulen JH, McArdle A, Jackson MJ, Faulkner JA: Contraction-induce injury to the extensor digitorum longus muscle of rats: the role of vitamin E. Eur J Appl Physiol 1997;83:817-823. (Pubitemid 27392301)
50. Alvarez R, Vazquez P, Pérez F, Jimenez A, Tirado A, Irles C, González-Serratos H, Ortega A: Regulation of fast skeletal muscle activity by SERCA1 vicinalcysteines. J Muscle Res Cell Motil 2009;30:5-16.
51. Parton RG, Hanzal-Bayer M, Hancock JF: Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J Cell Science 2006;119:787-796.
52. Reed PW, Mathews KD, Mills KA, Bloch RJ: The sarcolemma in the largemyd mouse. Muscle Nerve 2004;30:585-595.
53. Sotgia F, Kyung LJ, Das K, Bedford M, Petrucci CT: Caveolin-3 Directly Interacts with the C-terminal Tail of β-Dystroglycan. J Biol Chem 2000;275:38048-38058.
54. Bezakowa G, Ruegg AM: New insights into roles of agrin. Nat Rev Mol Cell Biology 2003;4:295-308.
55. Thompson PD, Clarkson P, Karas RH: Statin-Associated Myopathy. JAMA 2003;289:1681-1690. (Pubitemid 37430274)